+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Brovana"

Reversible Airway Diseases Treatment Global Market Report 2024 - Product Thumbnail Image

Reversible Airway Diseases Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Brovana is a brand of long-acting beta-agonist (LABA) medication used to treat chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it helps to open up the airways in the lungs, making it easier to breathe. Brovana is typically used in combination with other medications, such as inhaled corticosteroids, to provide the best relief from COPD symptoms. It is available in both an inhaler and a solution for nebulization. The Brovana market is a subset of the larger respiratory drugs market, which includes medications used to treat a variety of respiratory conditions, such as asthma, COPD, and cystic fibrosis. The market is highly competitive, with a number of different companies offering similar products. Some of the companies in the Brovana market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, and Sunovion Pharmaceuticals. Show Less Read more